Works matching IS 15391604 AND DT 2018 AND VI 17 AND IP 5

Results: 21

Evaluation of dependent variable, time effect, covariates, and covariation structure in concentration‐QTc modeling: A simulation study.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 607, doi. 10.1002/pst.1874

By:

Huang, Dalong (Patrick);
Xiao, Shan;
Dang, Qianyu;
Tsong, Yi

Publication type:

Article

Propensity score matched augmented controls in randomized clinical trials: A case study.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 629, doi. 10.1002/pst.1879

By:

Lin, Junjing;
Gamalo‐Siebers, Margaret;
Tiwari, Ram

Publication type:

Article

Weighted log‐rank test for time‐to‐event data in immunotherapy trials with random delayed treatment effect and cure rate.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 541, doi. 10.1002/pst.1878

By:

Liu, Shufang;
Chu, Chenghao;
Rong, Alan

Publication type:

Article

Robust Bayesian nonlinear mixed‐effects modeling of time to positivity in tuberculosis trials.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 615, doi. 10.1002/pst.1877

By:

Burger, Divan Aristo;
Schall, Robert;
Chen, Ding‐Geng

Publication type:

Article

Design and analysis of a 3‐arm noninferiority trial with a prespecified margin for the hazard ratio.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 489, doi. 10.1002/pst.1875

By:

Hida, Eisuke;
Tango, Toshiro

Publication type:

Article

Covariate adjustment and estimation of mean response in randomised trials.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 648, doi. 10.1002/pst.1880

By:

Bartlett, Jonathan W.

Publication type:

Article

A proposal for a new PhD level curriculum on quantitative methods for drug development.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 593, doi. 10.1002/pst.1873

By:

Jaki, T.;
Gordon, A.;
Forster, P.;
Bijnens, L.;
Bornkamp, B.;
Brannath, W.;
Fontana, R.;
Gasparini, M.;
Hampson, L. V.;
Jacobs, T.;
Jones, B.;
Paoletti, X.;
Posch, M.;
Titman, A.;
Vonk, R.;
Koenig, F.

Publication type:

Article

Effect of heteroscedasticity between treatment groups on mixed‐effects models for repeated measures.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 578, doi. 10.1002/pst.1872

By:

Gosho, Masahiko;
Maruo, Kazushi

Publication type:

Article

Sample size allocation in multiregional equivalence studies.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 570, doi. 10.1002/pst.1871

By:

Liao, Jason J. Z.;
Yu, Ziji;
Li, Yulan

Publication type:

Article

Decision‐making in drug development using a composite definition of success.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 555, doi. 10.1002/pst.1870

By:

Saint‐Hilary, Gaelle;
Robert, Veronique;
Gasparini, Mauro

Publication type:

Article

SPIRIT: A seamless phase I/II randomized design for immunotherapy trials.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 527, doi. 10.1002/pst.1869

By:

Guo, Beibei;
Li, Daniel;
Yuan, Ying

Publication type:

Article

Investigation of mixed model repeated measures analyses and non‐linear random coefficient models in the context of long‐term efficacy data.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 515, doi. 10.1002/pst.1868

By:

Delafont, Bruno;
Carroll, Kevin;
Vilain, Claire;
Pham, Emmanuel

Publication type:

Article

Missing data handling in non‐inferiority and equivalence trials: A systematic review.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 477, doi. 10.1002/pst.1867

By:

Rabe, Brooke A.;
Day, Simon;
Fiero, Mallorie H.;
Bell, Melanie L.

Publication type:

Article

Sample size determination and treatment screening in two‐stage phase II clinical trials via ROC curve.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 504, doi. 10.1002/pst.1866

By:

Huang, Wong‐Shian;
Chang, Yuan‐chin Ivan

Publication type:

Article

Design and inference for 3‐stage bioequivalence testing with serial sampling data.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 458, doi. 10.1002/pst.1865

By:

Yan, Fangrong;
Zhu, Huihong;
Liu, Junlin;
Jiang, Liyun;
Huang, Xuelin

Publication type:

Article

Randomised Response‐Adaptive Designs in Clinical Trials.

Published in:

2018

By:

Bell, Lauren

Publication type:

Book Review

Optimal planning of phase II/III programs for clinical trials with multiple endpoints.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 437, doi. 10.1002/pst.1861

By:

Kieser, Meinhard;
Kirchner, Marietta;
Dölger, Eva;
Götte, Heiko

Publication type:

Article

Dose‐escalation strategies which use subgroup information.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 414, doi. 10.1002/pst.1860

By:

Cotterill, Amy;
Jaki, Thomas

Publication type:

Article

Conditional estimation using prior information in 2‐stage group sequential designs assuming asymptotic normality when the trial terminated early.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 400, doi. 10.1002/pst.1859

By:

Shimura, Masashi;
Maruo, Kazushi;
Gosho, Masahiko

Publication type:

Article

Basic Statistics and Pharmaceutical Statistical Applications.

Published in:

2018

By:

Wang, Emma Yu

Publication type:

Book Review

Issue Information.

Published in:: Pharmaceutical Statistics, 2018, v. 17, n. 5, p. 397, doi. 10.1002/pst.1828
Publication type:: Article